Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 278-285 , July 2007

A specific training on hypertension guidelines improves blood pressure control by more than 10% in hypertensive patients: the VALNORM study

  • Roland Asmar, MD

      Affiliations

    • L’Institut Cardiovasculaire, Paris, France
    • Corresponding Author InformationCorresponding author: Roland Asmar, MD, The Cardiovascular Institute, 2, rue du Dr Blanche, 75116 Paris, France. Tel: + 331 55 74 66 66; fax: + 331 55 74 66 65.
    • ,
  • Assya Achouba, MD

      Affiliations

    • Novartis Pharma, Rueil-Malmaison, France
    • ,
  • Patrick Brunel, MD

      Affiliations

    • Novartis Pharma, Rueil-Malmaison, France
    • ,
  • Ramzi El Feghali, MS

      Affiliations

    • L’Institut Cardiovasculaire, Paris, France
    • ,
  • Thierry Denolle, MD

      Affiliations

    • Hôpital La Providence Gardiner, Dinard, France
    • ,
  • Bernard Vaisse, MD

      Affiliations

    • CHU La Timone, Marseille, France

References 

  1. Matillon Y. In ANAES: Efficacité des méthodes de mise en oeuvre des recommandations médicales. Available at: http://www.anaes.fr. Accessed Date: January 1, 2000.
  2. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (The JNC 7 complete version). Hypertension. 2003;42:1206–1252
  3. ESH/ESC Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–1053
  4. ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension Guidelines. J Hypertens. 2003;21:1779–1786
  5. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003;362:1527–1535
  6. Fagard RH, Van den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens. 2002;20:1297–1302
  7. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10–17
  8. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357:995–1001
  9. Hamilton-Craig CR, Tonkin AL, Jobling RG. How accurate are hypertension treatment decisions? Absolute risk assessment and prescribing for moderate hypertension (A study of Cambridge general practitioners). Blood Press. 2000;9:323–327
  10. Burnier M. Blood pressure control and the implementation of guidelines in clinical practice: can we fill the gap?. J Hypertens. 2002;20:1251–1253
  11. Shekelle PG, Park RE, Kahan JP, Leape LL, Kamberg CJ, Bernstein SJ. Validity of the agency for health care research and quality clinical practice guidelines (How quickly do guidelines become outdated?). JAMA. 2001;286:1461–1467
  12. Leape LL, Weisman JS, Schneider EC, Piana RN, Gatsonis C, Epstein AM. Adherence to practice guidelines: the role of specialty society guidelines. Am Heart J. 2003;145:19–26
  13. Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G, et al. Hypertension guidelines and their limitations—the impact of physician’s compliance as evaluated by guidelines awareness. J Hypertens. 2001;19:2079–2086
  14. Huse DM, Roht LH, Alpert JS, Hartz SC. Physician’s knowledge, attitudes, and practice of pharmacological treatment of hypertension. Ann Pharmacother. 2001;35:1173–1179
  15. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians (Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine). Arch Intern Med. 2000;160:2281–2286
  16. Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413–420
  17. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135:825–834
  18. Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Hypertension control: how well are we doing?. Arch Intern Med. 2003;163:2705–2711
  19. O’Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med. 2003;163:2677–2678
  20. Montgomery AA, Fahey T, Peters TJ, MacItosh C, Sharp DJ. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomized controlled trial. BMJ. 2000;320:686–690
  21. Bouvenot J, Gentile S, Ousset S, Tardieu S, Jouve E, Mendizabal H, et al. Facteurs influençant l’appropriation des recommandations médicales par les médecins. Presse Med. 2002;31:1831–1835
  22. ANAES. Prise en charge des patients adultes atteints d’hypertension artérielle essentielle. Recommandations cliniques et données économiques. Available at: http://www.anaes.fr. Acessed Date: April 1, 2000.
  23. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499–510
  24. Frijling BD, Lobo CM, Hulscher ME, Akkermans RP, van Drenth BB, Prins A, et al. Intensive support to improve clinical decision making in cardiovascular care: a randomized controlled trial in general practice. Qual Saf Health Care. 2003;12:181–187
  25. Goldstein M, Lavori Ph, Coleman R, Advani A, Hoffman BB. Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations. Am J Manag Care. 2005;11:677–685
  26. Roumie CL, Elasy TA, Greevy RG, Griffin MR, Liu X, Stone WJ, et al. Improving blood pressure control through provider education, provider alerts, and patient education — a cluster randomized trial. Ann Intern Med. 2006;145:165–175
  27. Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, et al. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol. 2004;60:135–142

 This study was supported by Novartis Pharma and approved by the French ethics committee, the Consultative Committee for People’s Protection within the framework of biomedical research — CCPPRB (registered under the reference 04009).Conflict of interest: none.

PII: S1933-1711(07)00088-5

doi: 10.1016/j.jash.2007.04.005

Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 278-285 , July 2007

Article Tools

* Image Usage & Resolution